Release 4B R5 Final QA

This page is part of the FHIR Specification (v4.3.0: R4B (v5.0.0-draft-final: Final QA Preview for R5 - STU see ballot notes ). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationrequest0312

Example MedicationRequest/medrx0312 (Narrative)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .


Generated Narrative Narrative: MedicationRequest

Resource MedicationRequest "medrx0312"

identifier : id: 12345689 (OFFICIAL) id: 12345689 (use: OFFICIAL)

priorPrescription : MedicationRequest/medrx0304

status : active

intent : order

Medications

- medication : Concept
* Phenytoin 25mg/ml oral suspension ( RxNorm #1313112)

subject : Patient/pat1: Donald Duck "Duck DONALD" "Donald DUCK"

authoredOn : 2015-01-15

requester : Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

- reasonCode : Concept
* Status epilepticus (disorder) ( SNOMED CT #230456007)

note : Patient should be counselled to ensure good dental hygiene

dosageInstruction

sequence : 1

text : 100mg (4ml) three times daily

timing : 3 per 1 days

route : Oral Route (qualifier value) ( SNOMED CT #26643006)

doseAndRate

dispenseRequest

validityPeriod : 2015-01-15 --> 2016-01-15

numberOfRepeatsAllowed : 3

quantity : 360 mL (Details: UCUM code mL = 'mL')

ExpectedSupplyDurations

- Value Unit System Code
* 30 days Unified Code for Units of Measure (UCUM) d

Substitutions

- Allowed[x] Reason
* true Continuing therapy ( ActReason #CT)
priorPrescription : MedicationRequest/medrx0304

 

Other examples that reference this example:

  • MedicationDispense/Oral suspension
  •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.